The 2025 summit offers an in-depth look at the most innovative technologies and scientific strategies shaping the future of microbiome-based therapies. This includes advancements in synthetic biology for strain optimization, computational models for clinical and commercial success, and leveraging AI and Big Data for drug discovery.
Sessions will explore not only early-stage discovery but also the critical steps required for clinical translation, regulatory approval, and commercial manufacturing. As the field matures, the need for scalable, GMP-compliant production processes and well-validated biomarkers becomes increasingly urgent—topics that will be addressed in both tracks of the summit.
Participants will also hear from leaders who have navigated the regulatory path for microbiome products, providing insights into working with the FDA and EMA, designing effective clinical trials, and building robust manufacturing pipelines.
With a forward-looking agenda and expert-led content, this year’s summit provides a clear picture of where the field is headed and how innovators can get there faster.
Register your place to make connections: https://ter.li/dxijz5
View the Event Guide to learn more: https://ter.li/s6rg77